Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial

Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record page updated its site revision/build label from v3.5.2 to v3.5.3, with no change to the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:34:47.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:51:42.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Updated the page revision to v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T01:02:28.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; the prior government funding lapse notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:38:05.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a site-wide notice about lapse in government funding and operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:39:36.000Z thumbnail image

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.